The authors said Paxlovid and molnupiravir ‘probably’ improve outcomes for outpatients with mild to moderate illness.
ACP issues updated Omicron-specific COVID-19 treatment guidance
Published in COVID-19
More from COVID-19More posts in COVID-19 »
May 4, 2024
The International Organization for the Proctection Against COVID-19
The authors said Paxlovid and molnupiravir ‘probably’ improve outcomes for outpatients with mild to moderate illness.
Published in COVID-19